Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy-Reference-Cited by-同舟云学术

Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy

Published:2022-01 Issue: Volume:824 Page:111776
ISSN:0027-5107
Container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
language:en
Short-container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Author:

Vakili-Samiani Sajjad,Khanghah Omid Joodi,Gholipour Elham,Najafi Fatemeh,Zeinalzadeh Elham,Samadi Parisa,Sarvarian Parisa,Pourvahdani Shiva,Kelaye Shohre Karimi,Hamblin Michael R.,Feizi Abbas Ali Hosseinpour

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology

Reference159 articles.

1. Cdc14 phosphatases preferentially dephosphorylate a subset of cyclin-dependent kinase (Cdk) sites containing phosphoserine;Bremmer;J. Biol. Chem.,2012

2. G1 and S-phase checkpoints, chromosome instability, and cancer;Nojima;Checkp. Controls Cancer.: Springe,2004

3. Cell cycle control and cell division: implications for chemically induced carcinogenesis;Luch;Chembiochem: a Eur. J. Chem. Biol.,2002

4. Mechanisms for initiating cellular DNA replication;Costa;Annu Rev. Biochem,2013

5. Cyclin-dependent kinases and S phase control in mammalian cells. Cell cycle (Georgetown;Woo;Tex),2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on small molecule compounds targeting synthetic lethality for cancer therapy;European Journal of Medicinal Chemistry;2024-11

2. Evaluating the Therapeutic Effect of Hispidin on Prostate Cancer Cells;International Journal of Molecular Sciences;2024-07-18

3. miRNAs in radiotherapy resistance of cancer; a comprehensive review;Cell Biochemistry and Biophysics;2024-05-28

4. Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review;Journal of Cancer Research and Clinical Oncology;2024-04-25

5. Construction of a prognostic model based on memory CD4+ T cell–associated genes for lung adenocarcinoma and its applications in immunotherapy;CPT: Pharmacometrics & Systems Pharmacology;2024-04-09